Testing effectiveness (Phase 2)Ended earlyNCT03791060
What this trial is testing
Secukinumab for NLD (Cosentyx) in Patients With Necrobiosis Lipoidica Diabeticorum (NLD)
Who this might be right for
Necrobiosis Lipoidica Diabeticorum
Beth Israel Deaconess Medical Center 4